Alessandro Armuzzi leads the Inflammatory Bowel Disease (IBD) Unit at the Presidio Columbus, Gemelli Hospital Catholic University Foundation in Rome, Italy. He earned his MD degree from the University of Bologna and his PhD degree from the Tor Vergata University of Rome, and completed his internal medicine and gastroenterology training at the Catholic University of Rome, all in Italy. Professor Armuzzi also conducted advanced research and underwent clinical training in IBD at the John Radcliffe Hospital – Oxford University Hospitals in Oxford, UK.
Professor Armuzzi’s research interests focus on the genetics of IBD, diagnostic modalities to assess Crohn’s disease activity, clinical prediction and outcomes in clinical trials, and biological therapy in IBD. He serves or has served as a member of several gastroenterology associations, including: the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) governing board, being Chair from 2018 to 2019; the Scientific Committee of the Italian Society of Gastroenterology (SIGE) from 2014 to 2017; and the European Crohn’s and Colitis Organisation (ECCO), of which he was ClinCom Workshop Chair from 2015 to 2017. Additionally, he has authored many peer-reviewed publications in the field of IBD.
EM-25598 - Date of preparation: January 2020